1. Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas. (3rd May 2014) Authors: Vaccaro, V.; Fabi, A.; Vidiri, A.; Giannarelli, D.; Metro, G.; Telera, S.; Vari, S.; Piludu, F.; Carosi, M. A.; Villani, V.; Cognetti, F.; Pompili, A.; Marucci, L.; Carapella, C. M.; Pace, A. Other Names: Rudà Roberta Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗